In our analysis, significant weight regain was observed only in the lower baseline BMI subgroups which did not conform to the common understanding, possibly because the enrolled patients were more severely obese and then not well differentiated by the BMI cutoff point, and the limited data in the analysis also reduced the confidence of the result
Since this is a compounded formulation and not an FDA-approved combination, seeking professional consultation is essential
A subcutaneous formulation received FDA approval in December 2017 as an adjunct to diet and exercise in adults with type 2 diabetes mellitus
These include the American Diabetes Association (ADA), the European Association for the Study of Diabetes (EASD), and the National Institute for Health and Care Excellence (NICE)
At the same time, Indian manufacturers are preparing to introduce generic semaglutide, which could disrupt pricing and market share dynamics post-2026